Tag: Advaxis

Clinical-stage pharma firms Ayala Pharmaceuticals, Advaxis sign merger deal

businessnewstoday- October 22, 2022

Ayala Pharmaceuticals, a Nasdaq-listed clinical-stage oncology company, has entered into a merger deal with New Jersey-based biotech company Advaxis. Based in Delaware, Ayala Pharmaceuticals is ... Read More

FDA lifts clinical hold on Advaxis’ Axalimogene Filolisbac, Durvalumab combo trial

pharmanewsdaily- July 15, 2018

Advaxis revealed that the US Food and Drug Administration (FDA) has removed a previously imposed clinical hold on its Phase 1/2 trial of Axalimogene Filolisbac ... Read More